Conflict of interest
Janssen, Johnson & Johnson,
G Parkes received personal payments/honoraria/speaker fees and/or accepted travel grants or fellowships from AbbVie, Allergan, BMS, Celltrion, Ferring, Galapagos, Janssen, Napp, Takeda, and Tillotts; and is a Director and Shareholder in Ampersand Health. RC Ungaro served as an advisory board member or consultant for AbbVie, BMS, Janssen, Pfizer, and Takeda and has research grants from AbbVie, BI, and Pfizer. S Danese has received consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Biogen, BI, Celgene, Celltrion, Ferring, Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer, Roche, Sandoz, Takeda, TiGenix, UCB, and Vifor Pharma. MT Abreu has been a consultant or served on an advisory board for, served as a teacher, lecturer, or speaker for, and/or has received grants/research support from AbbVie, Alimentiv, Arena, BMS, Gilead, Imedex, Intellisphere, LLC (HSCG) HCP Live Institutional Perspectives in GI, Janssen, Lilly, Microba, Pfizer, Prime, Prometheus, Takeda, and UCB. E Arenson is an employee of Adelphi Values and provides scientific support services within the pharmaceutical and device development industry. W Zhou, D Ilo, FS Laroux, and Y Sanchez Gonzalez are employees of AbbVie and may own stock or stock options. H Deng is a research fellow and student at University of Illinois at Chicago. L Peyrin-Biroulet received personal fees from Galapagos, AbbVie, Janssen, Genentech, Ferring, Tillots, Celltrion, Takeda, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Inotrem, Allergan, MSD, Roche, Arena, Gilead, Amgen, BMS, Vifor, Norgine, Mylan, Lilly, Fresenius Kabi, OSE Immunotherapeutics, Enthera, Theravance, Pandion Therapeutics, Gossamer Bio, Viatris, Thermo Fisher; grants from Abbvie, MSD, Takeda, Fresenius Kabi; has stock options with CTMA.